InvestSMART

Visionflex Group Limited (ASX: VFX) - Share Price

Current share price for VFX : $0.064 0.001 (0.79%)+

Visionflex Group Limited (VFX), an ASX-listed company, is a Company that is engaged in provision of healthcare, telehealth, and remote diagnostic solutions into both local and international markets.

VFX General Information +

ASX Code VFX
Website http://www.vfx-group.com
Industry/Sector Health Care Technology
Market Cap ($M) 5
VFX Share Price $0.064
Day High $0.064
Day Low $0.064
Last Close $0.063
VFX Share Price Movement $0.00 ( 0.79% )
Prices as at 16:40, 17 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Visionflex Group Limited (VFX) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Visionflex Group Limited (VFX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Visionflex Group Limited (VFX) price-sensitive announcements

VFX - Q4 FY26 Quarterly Activity Report
Visionflex Group Limited reported a successful Q4 FY26 with positive cash flow and strateg
Visionflex Group Limited (VFX)
13 Jul 2026 | 9:04 AM
VFX - Q4 FY26 Appendix 4C
The document is the Q4 FY26 Appendix 4C report for Visionflex Group Limited, detailing the
Visionflex Group Limited (VFX)
13 Jul 2026 | 9:03 AM
VFX - Visionflex Awarded NSW Health Contract to Supply Hardware
Visionflex Group Limited has been awarded a contract by NSW Health to supply approximately
Visionflex Group Limited (VFX)
26 Jun 2026 | 8:18 AM
VFX - Q3 FY26 Appendix 4C
The Q3 FY26 Appendix 4C report for Visionflex Group Limited details the company's financia
Visionflex Group Limited (VFX)
29 Apr 2026 | 8:45 AM

Visionflex Group Limited (VFX) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Visionflex Group Limited (VFX)
ORDINARY FULLY PAID
 Health Care $6 Q4 FY26 Quarterly Activity Report 13 Jul 2026 9:04AM $0.055 $0.064 risen by 15.45%
Visionflex Group Limited (VFX)
ORDINARY FULLY PAID
 Health Care $6 Q4 FY26 Appendix 4C 13 Jul 2026 9:03AM $0.055 $0.064 risen by 15.45%
Visionflex Group Limited (VFX)
ORDINARY FULLY PAID
 Health Care $6 Application for quotation of securities - VFX 29 Jun 2026 8:54AM $0.060 $0.064 risen by 5.83%
Visionflex Group Limited (VFX)
ORDINARY FULLY PAID
 Health Care $6 Visionflex Awarded NSW Health Contract to Supply Hardware 26 Jun 2026 8:18AM $0.035 $0.064 risen by 81.43%
Visionflex Group Limited (VFX)
ORDINARY FULLY PAID
 Health Care $6 Q3 FY26 Appendix 4C 29 Apr 2026 8:45AM $0.055 $0.064 risen by 15.45%
Visionflex Group Limited (VFX)
ORDINARY FULLY PAID
 Health Care $6 Q3 FY26 Quarterly Activity Report 29 Apr 2026 8:44AM $0.055 $0.064 risen by 15.45%

VFX Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$3.21 -$5.20 -4.10% 0.00 0.00 0.00% 0.0%
2024A -$1.53 -$5.40 -52.80% 0.00 0.00 0.00% 0.0%
2023A -$3.28 -$11.40 -64.70% 0.00 0.00 0.00% 0.0%

VFX Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
4DMedical Limited (4DX) $2,273M 0.3304 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Pro Medicus Limited (PME) $20,247M 0.3919 0.2545 0.2962 176.0309 140.3200 108.2556 0.28% 0.36% 0.47%
Visionflex Group Limited (VFX) $5M -0.0407 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

VFX Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 -2.34 0.00
Market 0.31 12.90 1.13 0.58
Sector 0.69 21.40 1.57 1.90

VFX Directors

Name Position Start Date
Mr Joshua Luke Mundey Chief Executive Officer, Managing Director 1 Mar 2025
Mr Michael Kafrouni Chief Operating Officer, Executive Director 1 Mar 2025
Mr Brook Adcock Non-Executive Director, Interim chairman 17 Jun 2022

Visionflex Group Limited (VFX) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
19 Nov 2025 ADCOCK, Brook Issued Indirect Shares 139,831,500 $0.004 $559,326.000
25 Jul 2024 WHITEHEAD, Christopher (Chris) Issued Direct Shares 2,493,080 $0.005 $12,465.400
25 Jul 2024 NEATE, Geoffrey Issued Indirect Shares 9,948,814 $0.005 $49,744.070

See all changes in directors' interest & trades for Visionflex Group Limited (VFX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

VFX Management

Name Position
James Aulsebrook Chief Financial Officer
Maria Clemente Company Secretary

VFX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Visionflex Group Limited (VFX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
1,129,621,510 (33.67%) John Charles Plummer
851,431,604 (25.38%) Adcock Private Equity Pty Limited
197,583,046 (5.89%) Michael John Harman

VFX Calendar of Events

Date Event
25 February 2027 Report (Interim)
28 August 2026 Report (Annual)
28 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.